Schedule 13G ownership disclosure

N/A

Common Stock · CUSIP: 78667J108

Event date: 2025-01-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BB Biotech AG

    Shares: 1,178,503 · Class: 1.9%

  • Biotech Target N.V.

    Shares: 1,178,503 · Class: 1.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-006473
Form type
SCHEDULE 13G/A
Filer
BB BIOTECH AG
CIK
CIK 924223
Filed
Jan 17, 2025
Reporting period
Jan 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub